Douglas J Swirsky Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas J Swirsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas J Swirsky. Douglas J Swirsky is Director in Fibrocell Science, Inc. ($FCSC) and Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and Chief Financial Officer in GENVEC INC ($GNVC) and President & CEO in GENVEC INC ($GNVC) and President and CEO in GENVEC INC ($GNVC) and President and CEO in REXAHN PHARMACEUTICALS, INC. ($RNN) and President and CFO in REXAHN PHARMACEUTICALS, INC. ($RNN) and Director in Cellectar Biosciences, Inc. ($CLRB) and Director in NeuroBo Pharmaceuticals, Inc. ($GEMP).
Latest Insider Trading Transactions of Douglas J Swirsky
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLRB, FCSC, GNVC, NRBO, RNN, GTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 03 2020 | GEMP | NeuroBo Pharmaceut ... | Swirsky Douglas J | Director | Option Exercise | A | 6.04 | 60,000 | 362,400 | 60,000 | |
| Jun 25 2020 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 1.28 | 80,000 | 102,400 | 80,000 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 1.94 | 12,000 | 23,280 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 2.36 | 6,000 | 14,160 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 16.55 | 6,000 | 99,300 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 14.25 | 2,400 | 34,200 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 81.60 | 2,400 | 195,840 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 62.10 | 1,200 | 74,520 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 82.35 | 1,600 | 131,760 | 0 | |
| Dec 13 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | D | 56.25 | 534 | 30,038 | 0 | |
| Jun 14 2019 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 2.15 | 9,750 | 20,963 | 9,750 | |
| Jun 14 2019 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | A | 1.94 | 12,000 | 23,280 | 12,000 | |
| Jan 30 2019 | RNN | REXAHN PHARMACEUTI ... | Swirsky Douglas J | President and CEO | Buy | P | 0.63 | 50,000 | 31,720 | 50,000 | 0 to 50 K |
| Nov 16 2018 | RNN | REXAHN PHARMACEUTI ... | Swirsky Douglas J | President and CEO | Option Exercise | A | 1.09 | 500,000 | 545,000 | 500,000 | |
| Oct 15 2018 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 2.61 | 19,500 | 50,895 | 19,500 | |
| Oct 15 2018 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 2.61 | 19,500 | 50,895 | 19,500 | |
| Jun 21 2018 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | A | 2.36 | 6,000 | 14,160 | 6,000 | |
| May 23 2018 | GTA | PERNIX THERAPEUTIC ... | Swirsky Douglas J | Director | Option Exercise | A | 2.63 | 25,000 | 65,750 | 25,000 | |
| Jan 04 2018 | RNN | REXAHN PHARMACEUTI ... | Swirsky Douglas J | President and CFO | Option Exercise | A | 2.10 | 250,000 | 525,000 | 250,000 | |
| Nov 17 2017 | GTA | PERNIX THERAPEUTIC ... | Swirsky Douglas J | Director | Option Exercise | A | 2.97 | 50,000 | 148,500 | 50,000 | |
| Jun 26 2017 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | A | 3.31 | 30,000 | 99,300 | 30,000 | |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Option Exercise | M | 5.60 | 25,000 | 140,000 | 0 | |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Sell | D | 0.00 | 29,320 | 0 | 0 | 29.3 K to 0 (-100.00 %) |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Payment of Exercise | F | 7.19 | 20,930 | 150,487 | 29,320 | 50.3 K to 29.3 K (-41.65 %) |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Buy | M | 5.60 | 25,000 | 140,000 | 50,250 | 25.3 K to 50.3 K (+99.01 %) |
| Jun 01 2017 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
| Sep 16 2016 | GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Buy | P | 0.50 | 10,000 | 5,000 | 252,500 | 242.5 K to 252.5 K (+4.12 %) |
| Jun 23 2016 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | A | 0.95 | 36,000 | 34,200 | 36,000 | |
| Feb 01 2016 | GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Option Exercise | A | 0.56 | 250,000 | 140,000 | 250,000 | |
| Dec 15 2015 | GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Buy | P | 2.00 | 5,000 | 10,000 | 242,500 | 237.5 K to 242.5 K (+2.11 %) |
| Jun 25 2015 | FCSC | Fibrocell Science, ... | Swirsky Douglas J | Director | Option Exercise | A | 5.44 | 36,000 | 195,840 | 36,000 | |
| Mar 19 2007 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Buy | P | 2.52 | 5,000 | 12,600 | 5,000 | 0 to 5 K |
| Jan 22 2007 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Option Exercise | A | 2.61 | 30,000 | 78,300 | 30,000 | |
| Sep 19 2006 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Option Exercise | A | 1.13 | 300,000 | 339,000 | 300,000 | |
| Sep 19 2006 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Option Exercise | A | 1.13 | 300,000 | 339,000 | 300,000 |
Page: 1